Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$724,830
+$142,574 QoQ
Shares Held
2,854
+19.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.97%
of 13F equity value
Holder Rank
#3,324
of 4,664 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Randall & Associates Wealth Management holds $1,687,972 across 2 Drug Manufacturers - General names. JNJ ranks #2 (42.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
803 | $963,142 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,854 | $724,830 |
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $724,830 | 2,854 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $582,256 | 2,382 | Shares | Sole | 2026-04-21 | |
| 2025-03-31 | $592,878 | 3,575 | Shares | Sole | 2025-04-09 | |
| 2024-09-30 | $508,220 | 3,136 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||